GENINUS Inc. (KOSDAQ:389030)
South Korea · Delayed Price · Currency is KRW 3,510.00
+135.00 (4.00%)
At close: Feb 27, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 117.06 billion as of February 27, 2026. Its market cap has increased by 156.20% in one year.
Market Cap
117.06B
Enterprise Value
111.72B
Revenue
8.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,510.00
Market Cap Chart
Since November 8, 2021, GENINUS's market cap has decreased from 145.65B to 117.06B, a decrease of -19.63%. That is a compound annual growth rate of -4.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 117.06B | 0.29% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
| Nov 8, 2021 | 145.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 458.95B |
| Dx & Vx | 453.76B |
| Cytogen | 126.42B |
| HLB Panagene | 90.85B |
| Green Cross Medical Science | 82.84B |
| Protia | 67.09B |
| Seoulin Bioscience | 58.08B |
| GeneMatrix | 47.01B |